Quince Therapeutics
QNCX
$0.96
Share price
-2.55%
Change (1 day)
-41.10%
Change (1 year)
Categories
Quince Therapeutics (QNCX) - Cash on Hand
Cash on Hand as of December 2023 : $75.05 M
According to Quince Therapeutics's latest financial reports the company has $75.05 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Quince Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $90.18 M | -15.56% |
| 2021-12-31 | $0.10 B | -20.19% |
| 2020-12-31 | $0.13 B | 34% |
| 2019-12-31 | $99.86 M | 39.25% |
| 2018-12-31 | $71.71 M | 876.66% |
| 2017-12-31 | $7.34 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 177.36% | 🇺🇸 USA |